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INTRODUCTION 
The effect of systemic diseases on the dental state has 
been studied from ancient [1,2] to modern times [3-5]. 
Indeed, often times it was and is the dentist who first 
suspects a severe systemic disease and guides a patient 
to a specialist. In the last decade there has been a growth 
both in cancer morbidity and survival rate [6], therefore, 
quality of life of such patients has become one of the major 
medical problems. ALL is considered the most common type 
of leukemia in children and holds a variety of oral cavity 
complications. 
Periodontal alterations in patients with leukemia are 
attributed to hematologic disorders [7] or are associated with 
chemotherapy and radiation therapy [8,9]. They can be noted 
at the early stage of leukemia [10], during chemotherapy 
[11], and during maintenance phases [12]. Despite the fact 
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that the late effects of leukemia treatment on gingival health 
have described in few articles [13-17], there were no studies 
evaluating gingival health from the time of diagnosis to the 
permanent remission phase.
This study is aimed at analysing the frequency of peri-
odontal diseases and at establishing the gingival indices in 
the different phases of ALL in children.
MATERIALS AND METHODS
The cross-sectional study involves 373 children aged 7-15 
years. All children in the study group were examined by 
one investigator. Among the 373 subjects, 213 healthy indi-
viduals formed the control group (group HC). Of these, 110 
were males and 103 were females. A total of 160 children 
(83 males and 77 females) who had been diagnosed with 
ALL and were already undergoing different phases of inten-
sive chemotherapy were selected for the study. The children 
underwent dental examination in the Pediatric Hematology 
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Ward of Chidren’s Hospital (Poltava, Ukraine). Patient selec-
tion was based on the following criteria: 
1. patients were newly diagnosed with ALL; 
2. the aims and requirements of the study were freely 
accepted by the parents; 
3. the recruitment, follow-up and compliance of patients;
4. patients with any systemic disease except ALL were 
excluded. 
Patients with ALL were categorized into three groups. 
Group L1 – 50 patients examined before the initiation 
therapy, group L2 – 50 patients examined after 1 month of 
the chemotherapy; group L3 – 60 patients examined while 
in permanent hematologic remission (1-5 years). Patients 
received hematologic treatment according to АLL-BMF-
REZ-95 and АLL-BMF-REZ-2002 protocols. The HC and 
L groups were divided into 2 subgroups: 7-11 years old 
and 12-15 years old. We enrolled 63 boys and 59 girls aged 
between 7-11 years of age in the HC group. Ethical approval 
was obtained from the Ethical Committee of Ukrainian 
Medical Stomatological Academy, and informed consent 
was obtained from all the study subjects (their parents). 
The children were instructed to clean their teeth with a soft 
brush, and rinse their mouths with the herbal mouthwash 
(Phytodent), but most children refused to clean their teeth in 
the chemotherapy phase due to strong gum bleeding.
Periodontal examination was performed in compli-
ance with the guidelines for periodontal screening [18]. 
Frequency of gingivitis and periodontitis was evaluated. 
In addition, the assessment of gingival inflammation was 
performed by Silness-Loe index [19], papilla-marginal index 
(PMA) modified by Parma [20] and papilla bleeding index 
(PBI) introduced by Saxer and Muhlemann [21]. A periodon-
tal probe was used for Silness-Loe and PBI indices (AEP 
WHO B; Hu-Friedy).
Categorical variables were analysed by Fisher’s exact 
test. Statistical significance level of p ≤ 0.05 was applied 
for all calculations.
RESULTS
Groups L1, L2, L3 had significantly worse gingival 
indices than group HC (p < 0.0001) both in 7-11 years-old 
(Table 1) and in 12-15 years-old children (Table 2). 
Gingival enlargement with spontaneous bleeding or 
bleeding on tooth brushing was revealed in group L1. 
Patients of group L2 demonstrated a high rate of necrotic, 
sloughing, gingival tissue with moderate erythema and 
multiple ulcerations. In HC and L3 groups, gingival enlarge-
ment without spontaneous bleeding dominated. One third 
of all 12-15 years-old children in the remission phase had 
multiple pockets, mostly < 4 mm.
The changes in the gingival indices represented intensity 
of gum inflammation in the different phases of ALL. In 
the 7-11 years-old children from group L2, these indices 
were significantly higher (Table 1) than that in group L1 
(p < 0.0001). In the children from group L3, a signifi-
cant decrease as compared to L2 group was found for all 
examined gingival indices (p < 0.0001). 
The 12-15 years-old children from group L1 (Table 2) 
had significantly higher gingival indices than did their 
healthy counterparts (p < 0.001) (Table 2). These indices 
were also significantly higher in group L2 than in group L1 
(p < 0.001). There was significant decrease in all gingival 
indices in 12-15 years-old children (p < 0.0001) from the L3 
group, as compared to the L2 group.
Table 1. The gingival indices in 7-11 years-old children in different 
phases of acute lymphoblastic leukemia
Group Number  of examined
РМА 
%
Silness-Loe 
scores
РВІ 
scores
HC 122 5.83±0.56 0.3±0.07 0.27±0.04
L1 28 16.71±2.7 0.85±0.05 1.45±0.07
L2 28 35.6±4.0 2.1±0.11 3.5±0.15
L3 30 28.9±2.9 1.6±0.13 1.5±0.11
HC – healthy controls; L1 – before the initiation phase, L2 – after 1 month  
of chemotherapy, L3 – the remission phase
Table 2. The gingival indices in 12-15 years-old children in 
different phases of acute lymphoblastic leukemia
Group Number  of examined
РМА 
%
Silness-Loe 
scores
РВІ 
scores
HC 91 6.0±0.84 0.73±0.06 0.32±0.12
L1 22 28.4±3.2 1.5±0.12 2.2±0.08
L2 22 41.6±3.04 2.3±0.14 3.6±0.14
L3 30 26.08±4.01 1.87±0.02 1,2±0,2
HC – healthy controls; L1 – before the initiation phase, L2 – after 1 month  
of chemotherapy, L3 – the remission phase
The Frequency of gingivitis in 12-15 years-old healthy 
children (Table 4) was higher than in 7-11 years-old children 
(Table 3) (p = 0.0005). In addition, the frequency of gingi-
vitis in 7-11 years-old children and 12-15 years-old children 
was higher in groups L1, L2, L3 (p < 0.0001) than in group 
HC, and increased over the course of disease. What is more, 
periodontitis was revealed in 12-15 years-old children from 
group L3 (Table 4). Total frequency of periodontal diseases 
was significantly higher in group L3 than in group L2 in 7-11 
years-old children (p < 0.0001) (Table 3) and insignificantly 
so in 12-15 years-old children (p > 0.1) (Table 4). 
Table 3. The gingivitis frequency in 7-11 years-old children in 
different phases of acute lymphoblastic leukemia
Groups Number  of examined
Number of children 
with gingivitis
Frequency  
of gingivitis, %
HC 122 25 20.5±3.6
L1 28 13 46.9±9.4
L2 28 22 78.6±7.7
L3 30 27 90.0±5.4
HC – healthy controls; L1 – before the initiation phase, L2 – after 1 month  
of chemotherapy, L3 – the remission phase
Table 4. The periodontitis frequency in 12-15 years-old children 
in different phases of acute lymphoblastic leukemia
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HC 91 39 42.8±5.2 - - 42.8±5.2
L1 22 18 81.8±8.2 - - 81.8±8.2
L2 22 20 91.0±6.3 - - 91.0±6.3
L3 30 19 63.3±10.2 10 33.3±8.6 96.6±3.3
HC – healthy controls; L1 – before the initiation phase, L2 – after 1 month  
of chemotherapy, L3 – the remission phase
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The results evidenced in Table 3 reveal there was signifi-
cant increase in frequency of gingivitis in 7-11 years-old 
children from the L2 group (p = 0.01) and from the L3 
group (p = 0.0004), as compared to the L1 group. In the 
12-15 years-old children from the L2 group, frequency of 
gingivitis increased nonsignificantly, as compared to the L1 
group (p = 0.31). Finally, insignificant increases in frequency 
of gingivitis in the L3 group, as compared with the L2 group 
were found in both subgroups (p > 0.2) (Table 3 and 4).
DISCUSSION
The results exhibit significant increases (p < 0.0001) in 
gingival indices in the L1, L2 and L3 patient groups when 
compared with the healthy group – as showed in Tables 1 
and 2. Results close to these in the presented study were 
obtained by Pels and Mielnik-Błaszczak (2012), who dem-
onstrated that Silness-Loe gingival index was significantly 
higher in children with ALL before chemotherapy than 
in healthy children [22]. The study of Sonis et al. (1995) 
showed that children prior to age 5 years with ALL who 
were treated with chemotherapy and radiotherapy and 
were at least 5 years in continuous remission had sig-
nificantly higher modified gingival index scores than did 
healthy children [13]. In a study by Avzar et al. (2007) 
of childhood cancer survivors who were in remission from 
0,5 to 7,2 years, significantly higher gingival index was 
found, compared to their healthy counterparts [17]. These 
changes probably resulted from the decreased immunity 
of the leukemia afflicted children and the cytotoxic effect 
of chemotherapy.
Dens et al. (1995), however, claimed that gingival index 
scores were the same in long-term survivors of pediatric 
malignancies and in healthy children [14]. The following 
points have to be taken into account: in that research only 
a half of the examined children had ALL, average length of 
remission was 9 years and age of children was from 2 to 17 
years. A normal gingival index was found by Welbury et al. 
(1984) in children/young adults aged from 3 to 20 years 
who had ALL or solid tumours and were in long remission 
(duration was not mentioned) [15]. We hypothesize that the 
normal values of gingival index in these studies might have 
been influenced by the variation of cancer pathologies, the 
great age difference and the duration of remission.
The results revealed in Tables 1 and 2 demonstrate that 
there were significant increases (p < 0.0001) in gingival 
indices in children after 1 month of the chemotherapy 
course. This study agrees with the finding of Azher and 
Shiggaon (2013) who reported that the modified gingival 
index in children with ALL aged 2-14 years was higher 
in the maintenance phase of the chemotherapy than in the 
induction phase [12]. Dholam et al. (2014) claimed that 
Silness-Loe index worsened in acute leukemic pediatric 
patients aged 5-15 years following first induction chemo-
therapy [23].
The current results are in disagreement with the study of 
Pels and Mielnik-Błaszczak (2012) who showed that children 
with ALL aged 2-18 years had better gingival index during 
chemotherapy than before chemotherapy as result of the 
regulated oral hygiene regime with two mouthwashes [22]. 
Unfortunately, in previous studies, patients were not 
followed up from the time of diagnosis to the remission 
phase. In the present study, Silness-Loe, modified PMA 
index and PBI results showed significantly decrease in the 
remission phase as compared to the chemotherapy phase 
(p < 0.0001). Of note, periodontal pockets were found in one 
third of 12-15 years-old children in the remission.
A natural peak prevalence of gingivitis has been deter-
mined in females and males with the onset of puberty [24, 
25]. Still, taking this into account, frequency of gingivitis 
was higher in 12-15 years-old healthy children (Table 4) than 
in 7-11 years-old children (Table 3) (p = 0.0005).
Due to significant difference in the gingivitis fre-
quency between patients with ALL and their healthy peers 
(p < 0.001), we hypothesize that ALL and its chemother-
apy accelerate periodontal diseases. Significant increase 
in frequency of gingivitis in the chemotherapy phase 
(p = 0.01) and in the remission phase (p = 0.0004) as 
compared to before the initiation phase was found in 7-11 
year-old children (Table 3). Insignificant increases in fre-
quency of gingivitis between different phases of ALL were 
found in the 12-15 years old subgroup (p > 0.2) because of 
the high rate of gingivitis in HC and L1 groups (Table 4).
Future research may develop a novel strategy for the peri-
odontal disease prevention in patients with ALL based on 
the pathogenesis of periodontal alterations.
CONCLUSIONS
Children with ALL from the before initiation to the per-
manent remission phase had significantly worse gingival 
health than did their healthy counterparts. Frequency of gin-
givitis also deteriorated over the clinical course of disease, 
whereas gingival indices increased after 1 month of chemo-
therapy and decreased in the permanent remission phase. 
Taking all these aspects into consideration, it can be con-
cluded that children with ALL not only require prevention 
courses before the initiation and during the chemotherapy 
phases, but in the permanent remission phase to minimize 
the long-term impact of leukemia treatment on gingival 
health. This is a future task for health-promotion research.
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